- About UCB
- Our Medicines
- Join Us
In Canada, UCB Canada Inc. is proud to lead and support a number of patient-focused programs and the efforts of healthcare professionals across the country.
E-Action™ – Taking Action Against Epilepsy, an initiative of UCB Canada Inc., is an educational and inspirational resource and community of individuals that strives to provide a caring and informative environment for those living with the disorder, their families and friends, healthcare professionals, and all Canadians who can benefit from learning more. E-Action™ includes four main sources of information and education: a magazine, a website, a mobile application (App), and a leader program.
To learn more about the E-Action program, please visit http://www.e-action.ca.
UCB Canada Inc. is one of the Canadian biopharmaceutical partners for Purple Day and has been instrumental in supporting the goals of this day of epilepsy awareness in Canada and around the world. Purple Day for Epilepsy is celebrated each year on March 26 and is dedicated to raising awareness about epilepsy. It helps reduce stigma and empowers individuals living with epilepsy to take action in their communities. Purple Day was founded in 2008 by then nine-year-old Cassidy Megan of Nova Scotia, and named after the internationally recognized colour for epilepsy, lavender. Purple Day was launched internationally in 2009 and is a legally recognized day for epilepsy awareness in Canada.
To learn more about Purple Day, please visit http://www.purpleday.org.
The first of its kind in Canada, The Impact of Epilepsy on Canadians survey was conducted to provide an in-depth look at how Canadian adults living with epilepsy are impacted by the disorder in terms of their quality of life, health, and access to care and treatment. Epilepsy is one of the most common neurological disorders affecting approximately 300,000 Canadians, or one in 100. Despite its wide reach, there is currently a lack of awareness and knowledge about epilepsy, which often leads to social isolation, work barriers and relationship issues. The general public and all levels of government require a better understanding of the impact of epilepsy to ensure that the correct and best care and support can be provided to those living with the disorder.
To learn more about the Impact of Epilepsy on Canadians Survey, please click here: The Impact of Epilepsy on Canadians Survey.
Established in 2006, the UCBeyond Scholarship Program has allocated more than 120 scholarships to Canadian students who have been diagnosed with inflammatory arthritis. Presented in partnership with The Arthritis Society, the scholarship is awarded to students who demonstrate academic ambition and embrace a way of life that goes above and beyond the boundaries of living with inflammatory arthritis.
For more information, please visit http://www.ucbeyond.ca.
The objective of this program is to empower patients who are taking CIMZA® for their chronic illness to take control of their health care pathway, from inception to end of therapy, with the assistance of a Registered Nurse. CIMZIASolutions™ is the only patient support program in inflammatory arthritis to provide a dedicated registered nurse for the patient. The program is flexible, transparent and provides many additional services valued by patients.
For more information, please visit http://www.cimziasolutions.ca.
UCB Canada Inc. is proud to support the discovery of new and better ways to treat and care for those living with severe diseases. This is accomplished through numerous educational grants, research fellowships and through providing support for Canadian investigator initiated studies within leading academic institutions, research centres and patient group associations. Some of our Canadian supported partners can be found below:
With a focus on CNS and Immunological diseases, we support research, education and awareness in these therapeutic areas. To apply for support, please visit: UCB Canada Funding